APA (7th ed.) Citation

M, C., J, P., U, Q., S, M., F, D., AM, A., . . . A, P. (2025). Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary center. World journal of gastrointestinal pharmacology and therapeutics, 16(4), 110273. https://doi.org/10.4292/wjgpt.v16.i4.110273

Chicago Style (17th ed.) Citation

M, Colwill, et al. "Risankizumab Is Effective Following Ustekinumab Failure in Crohn's Disease: A Real-world Study from a Tertiary Center." World Journal of Gastrointestinal Pharmacology and Therapeutics 16, no. 4 (2025): 110273. https://doi.org/10.4292/wjgpt.v16.i4.110273.

MLA (9th ed.) Citation

M, Colwill, et al. "Risankizumab Is Effective Following Ustekinumab Failure in Crohn's Disease: A Real-world Study from a Tertiary Center." World Journal of Gastrointestinal Pharmacology and Therapeutics, vol. 16, no. 4, 2025, p. 110273, https://doi.org/10.4292/wjgpt.v16.i4.110273.